134 related articles for article (PubMed ID: 35776993)
21. Impact of lymphovascular invasion in patients with stage I gastric cancer.
Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M
Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963
[TBL] [Abstract][Full Text] [Related]
22. Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.
Liu Q; Bi JJ; Tian YT; Feng Q; Zheng ZX; Wang Z
Asian Pac J Cancer Prev; 2015; 16(4):1665-9. PubMed ID: 25743789
[TBL] [Abstract][Full Text] [Related]
23. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
[TBL] [Abstract][Full Text] [Related]
25. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
26. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
27. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of lymphovascular invasion in node-negative gastric cancer.
Lee JH; Kim MG; Jung MS; Kwon SJ
World J Surg; 2015 Mar; 39(3):732-9. PubMed ID: 25376868
[TBL] [Abstract][Full Text] [Related]
30. Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature.
Wang S; Zheng G; Cheng B; Chen F; Wang Z; Chen Y; Wang Y; Xiong B
PLoS One; 2014; 9(6):e99259. PubMed ID: 24901848
[TBL] [Abstract][Full Text] [Related]
31. Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis.
Wang A; Tan Y; Geng X; Chen X; Wang S
Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30169614
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.
Santos C; López-Doriga A; Navarro M; Mateo J; Biondo S; Martínez Villacampa M; Soler G; Sanjuan X; Paules MJ; Laquente B; Guinó E; Kreisler E; Frago R; Germà JR; Moreno V; Salazar R
Colorectal Dis; 2013 Apr; 15(4):414-22. PubMed ID: 22974322
[TBL] [Abstract][Full Text] [Related]
33. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
[TBL] [Abstract][Full Text] [Related]
34. [Nutritional status predicts clinical outcomes in patients with gastric cancer undergoing radical gastrectomy].
Zhu XS; Zhao Y; Ma FY; Xuan L; Wu SK
Zhonghua Yi Xue Za Zhi; 2021 Feb; 101(6):421-428. PubMed ID: 33611892
[No Abstract] [Full Text] [Related]
35. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.
Liang JW; Zhang JJ; Zhang T; Zheng ZC
Tumour Biol; 2014 May; 35(5):4849-58. PubMed ID: 24449506
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
[TBL] [Abstract][Full Text] [Related]
38. Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer.
Matsuo K; Yoshino K; Hiramatsu K; Banzai C; Hasegawa K; Yasuda M; Nishimura M; Sheridan TB; Ikeda Y; Shiki Y; Mabuchi S; Enomoto T; Kimura T; Fujiwara K; Roman LD; Sood AK
Obstet Gynecol; 2014 May; 123(5):957-965. PubMed ID: 24785846
[TBL] [Abstract][Full Text] [Related]
39. Natural course of noncurative endoscopic resection of differentiated early gastric cancer.
Ahn JY; Jung HY; Choi JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH; Park YS
Endoscopy; 2012 Dec; 44(12):1114-20. PubMed ID: 23188661
[TBL] [Abstract][Full Text] [Related]
40. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
